Jill T. Johnson, Pharm.D., BCPS
Associate Professor
Department of Pharmacy Practice
Phone: (501) 686-7919
Fax: (501) 296-1168
Office: Education II Bldg 6/132G
Email: johnsonjillt@uams.edu

Education & Training:
Undergrad:  University of Arkansas, Fayetteville, AR
Professional:  University of Arkansas for Medical Sciences
Graduate:  1993, first Pharm.D. class
Residency Training:  John L. McClellan VA Medical Center, Pharmacy Practice
 

Teaching Responsibilities
List Course:
Therapeutics I
Therapeutics II
Pharmacokinetics
Evidence-based Medicine
Fourth-year Clerkships-General Internal Medicine Team 3A

Therapeutics:  Anemias, Sickle Cell Anemia, Fundamentals of Coagulation, Anticoagulant Drugs, Treatment of Venous Thromboembolism (VTE), Prevention of VTE, Anticoagulation of Heart Valves, Hypercoagulable States, Heparin-induced Thrombocytopenia, Anticoagulation of Atrial Fibrillation, Gastroesophageal Reflux Disease, Management of Gastrointestinal Bleeding, Peptic Ulcer Disease, Management of Ascites & Spontaneous Bacterial Peritonitis, Current Treatment of Hepatitis A, B & C,

Pharmacokinetics:  Heparin & Low-Molecular Weight Heparins, Warfarin

Evidence-based Medicine/Pharmacoeconomics:  Introduction to Evidence-based Medicine (EBM), The EBM Framework, EBM-Populations, External Validity, Considering Exclusion & Inclusion Criteria, EBM-The Study Design:  Controlled Trials & Randomization, EBM-Study Conduct:  Allocation Concealment, Blinding, Loss to Follow-up, and Accounting for Subjects, EBM-Results:  The Intention-to-Treat analysis vs The Per-Protocol Analysis, Impact of Baseline Characteristics, EBM-Results:  Calculating the Relative Risk, Number Needed to Treat, & Number Needed to Harm, Interpreting the Hazard Ratio, Odds Ratios, & 95% Confidence Intervals, EBM:  Composite Endpoints, The Differences in Baseline Characteristics when Randomization fails, Flawed Assumptions, and Run-In Periods, EBM-Study Interpretation:  Statistical vs clinical significance, EBM-Guideline Interpretation

Clinical Practice
University Hospital Team 3A General Internal Medicine-since 1993
Committee Involvement with Formulary Management-since 2004

Research & Scholarly Interests
Impact of Formulary Management Interventions on Utilization, Costs, and Health Improvement

Memberships
American College of Clinical Pharmacy (ACCP)
American Association of Colleges of Pharmacy (AACP)
Arkansas Pharmacists' Association (APA)
Rho Chi Pharmacy Honor Society
American Society of Health-Systems Pharmacists (ASHP)

Curriculum Vitae

Publications